Potential Shift From Quarterly Earnings Traders Eye Possible Timeline Changes Chinas Seven Titans Tech Stocks Decline as Deflation Pressures Override AI Optimism BP Chairman Removed Abruptly Amid Allegations of Bullying and Overbearing Conduct CEOs 1 Million Share Purchase Sparks Market Attention for NIQ Global Intelligence Crossroads Capitals Thesis on Nebius Group NBIS Shows Promise Amid Market Turmoil Spains Youth Housing Crisis Rent Consumes 987 of Young Workers Pay Emancipation Rate at Record Low INAB Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Advances Pipeline HTO Q1 2026 Earnings EPS Beats Estimates by 533 Shares Dip Modestly OPCH Q1 2026 Earnings EPS Beats Estimates Stock Declines Despite Beat FIGS Q1 2026 Earnings EPS Surges Past Estimates Amid 96 Surprise Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Workhorse Group Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Investcorp Credit Management BDC Inc ICMB Edges Higher Amid Tight Trading Range Hologic Inc HOLX Holds Steady at 7601 as Traders Eye Key 7981 Ceiling Upland Software UPLD Edges Lower Near Key Support Level VICI Properties VICI Holds Steady Near 2850 as REIT Sector Weighs Macro Headwinds United Homes Group Warrant UHGWW Holds Steady at 023 as Trading Range Narrows Morgan Stanley Lowers Equinor Price Target Following FirstQuarter Results Passage Bio Q1 2026 Earnings Narrowerthanexpected loss signals disciplined spending CSG Systems Holds Steady at 8069 as Support and Resistance Levels Come into Focus Microsofts Responsible Tech Lead Outlines Approach to Humanizing Rapid AI Development Deutsche Bank Raises Golar LNG Price Target Signaling Potential Upside Andaman Offshore Exploration Reveals Hydrocarbon Potential Gas Find with 87 Methane FIS Secures Major Client Wins Signaling Potential Turnaround Momentum AIDriven Layoffs Not a Guaranteed Boost for Stock Performance UltraRich in Germany Control Over 25 of Financial Wealth BCG Report Reveals Tony Blairs Economic Blueprint Diagnosis on Point Prescription Under Fire